Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP663314.RAyKryi49tZkro-krwJDGHHmAXqM7hZcku50oNZ4YW1EU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP663314.RAyKryi49tZkro-krwJDGHHmAXqM7hZcku50oNZ4YW1EU130_assertion type Assertion NP663314.RAyKryi49tZkro-krwJDGHHmAXqM7hZcku50oNZ4YW1EU130_head.
- NP663314.RAyKryi49tZkro-krwJDGHHmAXqM7hZcku50oNZ4YW1EU130_assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP663314.RAyKryi49tZkro-krwJDGHHmAXqM7hZcku50oNZ4YW1EU130_provenance.
- NP663314.RAyKryi49tZkro-krwJDGHHmAXqM7hZcku50oNZ4YW1EU130_assertion evidence source_evidence_literature NP663314.RAyKryi49tZkro-krwJDGHHmAXqM7hZcku50oNZ4YW1EU130_provenance.
- NP663314.RAyKryi49tZkro-krwJDGHHmAXqM7hZcku50oNZ4YW1EU130_assertion SIO_000772 21535412 NP663314.RAyKryi49tZkro-krwJDGHHmAXqM7hZcku50oNZ4YW1EU130_provenance.
- NP663314.RAyKryi49tZkro-krwJDGHHmAXqM7hZcku50oNZ4YW1EU130_assertion wasDerivedFrom befree-20140225 NP663314.RAyKryi49tZkro-krwJDGHHmAXqM7hZcku50oNZ4YW1EU130_provenance.
- NP663314.RAyKryi49tZkro-krwJDGHHmAXqM7hZcku50oNZ4YW1EU130_assertion wasGeneratedBy ECO_0000203 NP663314.RAyKryi49tZkro-krwJDGHHmAXqM7hZcku50oNZ4YW1EU130_provenance.